Table 1.
Population sample | Patient sample | P-value1 | |||||
Men | Women | Total | Men | Women | Total | ||
600 | 705 | 1305 | 25 | 163 | 188 | ||
Age, mean (sd) | 47.4 (14.1) | 46.8 (14.3) | 47.1 (14.2) | 52.4 (14.7) | 56.0 (10.8) | 55.5 (11.5) | <0.0001 |
| |||||||
QEESI (median) | P-value2 | ||||||
| |||||||
Symptoms | 9.0 | 14.0 | 11.0 | 35.0 | 48.0 | 47.0 | <0.0001 |
Chemical Int. | 11.0 | 15.0 | 13.0 | 81.6 | 82.2 | 82.1 | <0.0001 |
Other Int. | 6.0 | 12.0 | 10.0 | 27.3 | 35.5 | 35.0 | <0.0001 |
Life Impact | 0.0 | 3.0 | 2.0 | 70.0 | 64.0 | 65.0 | <0.0001 |
Masking Index | 4.0 | 4.0 | 4.0 | 2.0 | 2.0 | 2.0 | <0.0001 |
| |||||||
SCL-92 (median) | |||||||
| |||||||
Depression | 0.15 | 0.31 | 0.23 | 0.62 | 0.69 | 0.69 | <0.0001 |
Somatisation | 0.25 | 0.33 | 0.33 | 0.83 | 1.0 | 1.0 | <0.0001 |
| |||||||
SCL-92 (mean) | |||||||
| |||||||
Depression | 0.39 | 0.53 | 0.47 | 1.0 | 0.86 | 0.88 | — |
Somatisation | 0.38 | 0.51 | 0.45 | 1.0 | 1.13 | 1.12 | — |
| |||||||
Occupational social class (n (%)) | P-value3 | ||||||
| |||||||
<0.0001 | |||||||
I + II: | 224 (17.2) | 17 (9.0) | |||||
III + IV: | 426 (32.6) | 35 (18.5) | |||||
V + VI + VII: | 566 (43.4) | 124 (65.6) | |||||
Missing: | 89 (6.8) | 13 (6.9) |
Occupational social class: I + II: professionals and executives and medium-level white-collar employees; III + IV: low-level white-collar employees and skilled workers; V + VI + VII: unskilled and semiskilled workers, individuals receiving pension or disability benefits, and students.
1Independent samples t-test for equality of means (total) between population and patient samples.
2Mann-Whitney test (total) comparing population and patient samples.
3Chi-squared test comparing population and patient samples.